| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |